Christine McMahon, MD
Assistant Professor, Medicine-Hematology

Photo
Medical School:
  • MD, Duke University School of Medicine (2012)
Undergraduate School:
  • BA/BS, Duke University (NC) (2007)
Internship:
  • University of Pennsylvania Program (2013)
Residency:
  • Hospital of the University of Pennsylvania, Internal Medicine (2015)
Fellowships:
  • Hospital of the University of Pennsylvania, Hematology and Oncology (2018)
Department: Medicine-Hematology

Professional Titles

  • Assistant Professor of Medicine

Research Interests

Dr. McMahon is focused on clinical trials and translational studies for AML and MDS. Her previous research has focused on mechanisms of response and resistance to FLT3 inhibitors in acute myeloid leukemia.

Publications

  • Nelson ND, McMahon CM, El-Sharkawy Navarro F, Freyer CW, Roth JJ, Luger SM, Bagg A, Morrissette JJD. Rapid fluorescence in situ hybridisation optimises induction therapy for acute myeloid leukaemia. Br J Haematol. 2020 Dec;191(5):935-938. PubMed PMID: 33460058
  • Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J, Bhatt VR, Sekeres MA, Fathi AT, Konig H, Luger S, Khan I, Roboz GJ, Cluzeau T, Martínez-Cuadron D, Raffoux E, Germing U, Umakanthan JM, Mukherjee S, Brunner AM, Miller A, McMahon CM, Ritchie EK, Rodríguez-Veiga R, Itzykson R, Boluda B, Rabian F, Tormo M, Acuña-Cruz E, Rabinovich E, Yoo B, Cano I, Podoltsev NA, Bewersdorf JP, Gore S, Zeidan AM. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia. 2020 Dec;34(12):3149-3160. PubMed PMID: 32132655
  • Shallis RM, Stahl M, Wei W, Montesinos P, Lengline E, Neukirchen J, Bhatt VR, Sekeres MA, Fathi AT, Konig H, Luger S, Khan I, Roboz GJ, Cluzeau T, Martínez-Cuadron D, Raffoux E, Germing U, Umakanthan JM, Mukhereje S, Brunner AM, Miller A, McMahon CM, Ritchie EK, Rodríguez-Veiga R, Itzykson R, Boluda B, Rabian F, Tormo M, Acuña-Cruz E, Rabinovich E, Yoo B, Cano I, Podoltsev NA, Bewersdorf JP, Gore S, Zeidan AM. Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy. Leuk Lymphoma. 2020 May;61(5):1220-1225. PubMed PMID: 32100599
  • Abbott D, Cherry E, Amaya M, McMahon C, Schwartz M, Winters A, Schowinsky J, Jordan CT, Smith C, Gutman JA, Pollyea DA. The propriety of upgrading responses to venetoclax azacitidine in newly diagnosed patients with acute myeloid leukemia. Leuk Lymphoma. 2020 Dec 30:1-9. [Epub ahead of print] PubMed PMID: 33375853

Professional Memberships

  • American Society of Hematology, Member
  • American Society of Clinical Oncology, Member

Practice Locations

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400

UCH - Anschutz Inpatient Pavilion
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Hematology, Board Certification (2019, 2019)
  • Medical Oncology, Board Certification (2018, 2018)
  • Internal Medicine, Board Certification (2015, 2015)
Conditions & Treatments
  • Cancers - Leukemia (Adult Acute)
  • Cancers
  • Cancers - Myelodysplastic Syndrome
  • Cancers - Leukemia (Adult Chronic)
Clinical Interests
Dr. McMahon's primary clinical interests are in the management of acute myeloid leukemia, myelodysplastic syndromes, and chronic myeloid leukemia.

General Information

Medical Schools:
  • MD, Duke University School of Medicine (2012)
Undergraduate Schools:
  • BA/BS, Duke University (NC) (2007)
Internships:
  • University of Pennsylvania Program (2013)
Residency Programs:
  • Hospital of the University of Pennsylvania, Internal Medicine (2015)
Fellowships:
  • Hospital of the University of Pennsylvania, Hematology and Oncology (2018)
Department: Medicine-Hematology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;